Administration costs of intravenous biologic drugs for rheumatoid arthritis

por Soini, Erkki J, Leussu, Miina, Hallinen, Taru
Publicado 2013

Cost–Utility of First-Line Actinic Keratosis Treatments in Finland

por Soini, Erkki J., Hallinen, Taru, Sokka, Anna-Leena, Saarinen, Kari
Publicado 2015

Cost–effectiveness of apixaban and warfarin in the prevention of thromboembolic complications among atrial fibrillation patients

por Hallinen, Taru, Soini, Erkki J., Linna, Miika, Saarni, Samuli I.
Publicado 2016

Cost–utility of different treatment strategies after the failure of tumour necrosis factor inhibitor in rheumatoid arthritis in the Finnish setting

por Hallinen, Taru A., Soini, Erkki J. O., Eklund, Kari, Puolakka, Kari
Publicado 2010

Warfarin treatment among Finnish patients with atrial fibrillation: retrospective registry study based on primary healthcare data

por Hallinen, Taru, Soini, Erkki J, Asseburg, Christian, Kuosmanen, Pekka, Laakkonen, Ari
Publicado 2014

Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland

por Hallinen, Taru, Kivelä, Santtu, Soini, Erkki, Harjola, Veli-Pekka, Pesonen, Mari
Publicado 2023

Cost-effectiveness of pulse-echo ultrasonometry in osteoporosis management

por Soini, Erkki, Riekkinen, Ossi, Kröger, Heikki, Mankinen, Petri, Hallinen, Taru, Karjalainen, Janne P
Publicado 2018

Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atria...

por Hallinen, Taru, Soini, Erkki, Asseburg, Christian, Linna, Miika, Eloranta, Pia, Sintonen, Sari, Kosunen, Mikko
Publicado 2021

Differential use of extended and immediate release quetiapine: a retrospective registry study of Finnish inpatients with schizophrenia spectrum and bipolar disorders

por Hallinen, Taru, Soini, Erkki J, Granström, Ola, Ovaskainen, Yrjö, Leinonen, Esa, Koponen, Hannu J, Hänninen, Kari
Publicado 2012

Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis

por MÄLKÖNEN, Tarja, NUUTINEN, Pauliina, HALLINEN, Taru, SOINI, Erkki, NISSINEN, Riikka, WENNERSTRÖM, Christina, RANTANEN, Tapio, HAGMAN, Johanna H., HARVIMA, Rauno, HÖÖK-NIKANNE, Johanna, ILVES, Tiina, LINTU, Päivi, MALANIN, Ken, SORAMÄKI, Iina, TASANEN, Kaisa, TEHO, Arja, VÄHÄVIHU, Katja, ITÄLINNA, Sari, LEINONEN, Pekka, SARAJÄRVI, Piia, HUILAJA, Laura, PASTERNACK, Rafael
Publicado 2022

Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn’s disease cohort

por af Björkesten, Clas-Göran, Ilus, Tuire, Hallinen, Taru, Soini, Erkki, Eberl, Anja, Hakala, Kalle, Heikura, Mikko, Jussila, Airi, Koskela, Ritva, Koskinen, Inka, Moilanen, Veikko, Nielsen, Christian, Nieminen, Urpo, Nuutinen, Heikki, Heikkinen, Markku, Suhonen, Ulla-Maija, Tillonen, Jyrki, Utriainen, Karri, Vihriälä, Ilkka, Wennerström, Christina, Borsi, Andras, Nissinen, Riikka, Koivunen, Minni R., Sipponen, Taina
Publicado 2020